Logo image of NXH.CA

NEXT HYDROGEN SOLUTIONS INC (NXH.CA) Stock Fundamental Analysis

TSX-V:NXH - CA65345D1087 - Common Stock

0.46 CAD
+0.01 (+2.22%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

1

NXH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 22 industry peers in the Machinery industry. Both the profitability and financial health of NXH have multiple concerns. NXH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NXH has reported negative net income.
NXH had a negative operating cash flow in the past year.
In the past 5 years NXH always reported negative net income.
In the past 5 years NXH always reported negative operating cash flow.
NXH.CA Yearly Net Income VS EBIT VS OCF VS FCFNXH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

NXH has a worse Return On Assets (-102.13%) than 86.36% of its industry peers.
Industry RankSector Rank
ROA -102.13%
ROE N/A
ROIC N/A
ROA(3y)-61.32%
ROA(5y)-83.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXH.CA Yearly ROA, ROE, ROICNXH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

NXH has a better Gross Margin (73.29%) than 100.00% of its industry peers.
NXH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXH.CA Yearly Profit, Operating, Gross MarginsNXH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100K -200K -300K

0

2. Health

2.1 Basic Checks

NXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NXH has about the same amount of shares outstanding.
The debt/assets ratio for NXH is higher compared to a year ago.
NXH.CA Yearly Shares OutstandingNXH.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
NXH.CA Yearly Total Debt VS Total AssetsNXH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

NXH has an Altman-Z score of -11.85. This is a bad value and indicates that NXH is not financially healthy and even has some risk of bankruptcy.
NXH has a Altman-Z score of -11.85. This is amonst the worse of the industry: NXH underperforms 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.85
ROIC/WACCN/A
WACC8.78%
NXH.CA Yearly LT Debt VS Equity VS FCFNXH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.81 indicates that NXH may have some problems paying its short term obligations.
With a Current ratio value of 0.81, NXH is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
A Quick Ratio of 0.34 indicates that NXH may have some problems paying its short term obligations.
With a Quick ratio value of 0.34, NXH is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.34
NXH.CA Yearly Current Assets VS Current LiabilitesNXH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

The earnings per share for NXH have decreased strongly by -17.25% in the last year.
NXH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.59%.
Measured over the past years, NXH shows a very strong growth in Revenue. The Revenue has been growing by 97.22% on average per year.
EPS 1Y (TTM)-17.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.07%
Revenue 1Y (TTM)-24.59%
Revenue growth 3Y97.22%
Revenue growth 5YN/A
Sales Q2Q%-42.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 68.38% on average over the next years. This is a very strong growth
EPS Next Y-1.64%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year194.29%
Revenue Next 2Y115.43%
Revenue Next 3Y89.95%
Revenue Next 5Y68.38%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NXH.CA Yearly Revenue VS EstimatesNXH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M
NXH.CA Yearly EPS VS EstimatesNXH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

NXH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXH.CA Price Earnings VS Forward Price EarningsNXH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXH.CA Per share dataNXH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NXH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEXT HYDROGEN SOLUTIONS INC

TSX-V:NXH (8/22/2025, 7:00:00 PM)

0.46

+0.01 (+2.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-11 2025-11-11
Inst Owners17.6%
Inst Owner ChangeN/A
Ins Owners24.57%
Ins Owner ChangeN/A
Market Cap10.64M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.51
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.05
BVpS-0.18
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.29%
FCFM N/A
ROA(3y)-61.32%
ROA(5y)-83.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.95%
Cap/Sales 102.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.34
Altman-Z -11.85
F-Score3
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)310.79%
Cap/Depr(5y)310.08%
Cap/Sales(3y)291.83%
Cap/Sales(5y)1279.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.07%
EPS Next Y-1.64%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.59%
Revenue growth 3Y97.22%
Revenue growth 5YN/A
Sales Q2Q%-42.38%
Revenue Next Year194.29%
Revenue Next 2Y115.43%
Revenue Next 3Y89.95%
Revenue Next 5Y68.38%
EBIT growth 1Y-19.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.79%
EBIT Next 3Y9.57%
EBIT Next 5Y10.87%
FCF growth 1Y16.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.9%
OCF growth 3YN/A
OCF growth 5YN/A